Happy New Year 2016! From Us- TO US!

Editor’s Note:

I am amazed at the responses and enthusiasm that so many different perfusionists from all corners of the world have regarding our global community! True camaraderie and mutual respect from all of us to each other- realizing that we are the only ones on this planet that truly understand what a wonderful thing it is we do 🙂

Below are the many posts from groups all over the world that Bryan and I have received on our facebook pages- Perfusion.com and Surfers-

Take a minute to check them out- it underscores our professional pride as well as pure joy we take in doing one of the hardest jobs out there-

Peace to all of you!

Frank 🙂

Welcome to 2016!!!

Frank Aprile

Leave a Reply Cancel reply

You must be logged in to post a comment.

Remdesivir and its main active metabolite GS‐441524 are rapidly eliminated from the perfusate by the CytoSorb® adsorber device in vitro. This should be considered in patients for whom both therapies are indicated, and simultaneous application should be avoided. In general, plasma levels of therapeutic drugs should be closely monitored under concurrent CytoSorb® therapy.

Main Zone, Mobile Zone, Perfusion Zone

Direct Innominate Artery Cannulation for Antegrade Cerebral Perfusion in Neonates undergoing Arch Reconstruction

The purpose of the present study was to evaluate the flow measurements and safety of DC when compared with IC.

Main Zone, Mobile Zone, Perfusion Zone

Remote Ischemic Preconditioning: The Surgeon’s Perspective

Remote ischemic preconditioning, with the use of brief episodes of ischemia and reperfusion of vascular territories remote from the heart, has been shown convincingly to decrease myocardial injury.